《大行報告》匯豐研究上調中石油(00857.HK)目標價至2.56元 維持「持有」評級
匯豐環球研究發表報告表示,中石油(00857.HK)上半年虧損300億元人民幣,一如預期中疲弱,首季及次季分別錄虧損133億及167億元人民幣,公司管理層稱近期經營有所改善,而中期息按年增加13%至8.7分人民幣,該行預期下半年將仍會有穩定股息,相當於年化之股息收益率達7.4%
該行表示,基於油價的反彈,將對中石油今年度每股盈利預測由0升至0.18元人民幣,同時上調2021至2022年盈利預測49.3%及45%,將中石油目標價由2.3元升至2.56元,相當於明年市賬率0.33倍,維持中石油H股「持有」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.